Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|May 15, 2023
Identification of calcium and integrin-binding protein 1 as a reprogrammed glucose metabolism mediator to restrict immune cell infiltration in the stromal compartment of pancreatic ductal adenocarcinomaJunrui Ma, Yue Song, Tongtao Zhuang, et al.
Clinical Epigenetics|July 23, 2021
Genome-wide DNA methylome analysis identifies methylation signatures associated with survival and drug resistance of ovarian cancersDavid W Chan, Wai-Yip Lam, Fushun Chen, et al.
Plos One|January 10, 2013
AMPK activators suppress cervical cancer cell growth through inhibition of DVL3 mediated Wnt/β-catenin signaling activityH T Kwan, David W Chan, Patty C H Cai, et al.
Plos One|January 4, 2013
Targeting GRB7/ERK/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cellsDavid W Chan, Winnie W Y Hui, Patty C H Cai, et al.
Experimental Hematology & Oncology|August 28, 2024
Polyunsaturated fatty acids promote M2-like TAM deposition via dampening RhoA-YAP1 signaling in the ovarian cancer microenvironmentHuogang Wang, Mingo Mh Yung, Yang Xuan, et al.
Oncoimmunology|June 7, 2018
PD-L1 expression is a prognostic factor in subgroups of gastric cancer patients stratified according to their levels of CD8 and FOXP3 immune markersLe Ying, Feng Yan, Qiaohong Meng, et al.
Oncotarget|October 4, 2014
Elevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NF-κB signalingPatty C H Cai, Lei Shi, Vincent W S Liu, et al.
Communications Biology|August 3, 2019
Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cellsRain R Chen, Mingo M H Yung, Yang Xuan, et al.
Oncogene|September 1, 2018
miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancerJing Sun, Xin Cai, Mingo Mh Yung, et al.
Molecular Cancer|January 19, 2017
MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axisCelia S L Mak, Mingo M H Yung, Lynn M N Hui, et al.
Pageof 6